Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGF gene variants

被引:70
作者
Barreto, Marta [1 ]
Ferreira, Ricardo C. [1 ]
Lourenco, Lara [1 ]
Moraes-Fontes, Maria F. [1 ]
Santos, Eugenia [2 ,3 ]
Alves, Miguel [3 ]
Carvalho, Claudia [4 ]
Martins, Berta [4 ,5 ]
Andreia, Rita [2 ]
Viana, Joao F. [2 ]
Vasconcelos, Carlos [2 ]
Mota-Vieira, Luisa [6 ]
Ferreira, Carlos [2 ,3 ]
Demengeot, Jocelyne [1 ]
Vicente, Astrid M. [1 ,7 ]
机构
[1] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal
[2] Associacao Doentes Com Lupus, P-1000110 Lisbon, Portugal
[3] Clin Univ Med II, Hosp Santa Maria, P-1649035 Lisbon, Portugal
[4] Inst Ciencias Biomed Abel Salazar, P-4099003 Oporto, Portugal
[5] Inst Nacl Saude Dr Ricardo Jorge, P-4049019 Oporto, Portugal
[6] Hosp Div Espirito Santo Ponta Delgada, EPE, P-9500370 Ponta Delgada, Azores, Portugal
[7] Inst Nacl Saude Dr Ricardo Jorge, P-1600560 Lisbon, Portugal
关键词
REGULATORY T-CELLS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; IMMUNOLOGICAL SELF-TOLERANCE; IN-VIVO EXPANSION; AUTOANTIBODY PRODUCTION; MULTIPLE-SCLEROSIS; PERIPHERAL-BLOOD; MURINE LUPUS; ANTIGEN; DISEASE;
D O I
10.1186/1471-2172-10-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: CD4(+)CD25(+) regulatory T cells play an essential role in maintaining immune homeostasis and preventing autoimmunity. Therefore, defects in Treg development, maintenance or function have been associated with several human autoimmune diseases including Systemic Lupus Erythematosus (SLE), a systemic autoimmune disease characterized by loss of tolerance to nuclear components and significantly more frequent in females. Results: To investigate the involvement of Treg in SLE pathogenesis, we determined the frequency of CD4(+)CD25(+)CD45RO(+) T cells, which encompass the majority of Treg activity, in the PBMC of 148 SLE patients (76 patients were part of 54 families), 166 relatives and 117 controls. SLE patients and their relatives were recruited in several Portuguese hospitals and through the Portuguese Lupus Association. Control individuals were blood donors recruited from several regional blood donor centers. Treg frequency was significantly lower in SLE patients than healthy controls (z = -6.161, P < 0.00001) and intermediate in the relatives' group. Remarkably, this T cell subset was also lower in females, most strikingly in the control population (z = 4.121, P < 0.001). We further ascertained that the decreased frequency of Treg in SLE patients resulted from the specific reduction of bona fide FOXP3(+)CD4(+)CD25(+) Treg. Treg frequency was negatively correlated with SLE activity index (SLEDAI) and titers of serum anti-dsDNA antibodies. Both Treg frequency and disease activity were modulated by IVIg treatment in a documented SLE case. The segregation of Treg frequency within the SLE families was indicative of a genetic trait. Candidate gene analysis revealed that specific variants of CTLA4 and TGF were associated with the decreased frequency of Treg in PBMC, while FOXP3 gene variants were associated with affection status, but not with Treg frequency. Conclusion: SLE patients have impaired Treg production or maintenance, a trait strongly associated with SLE disease activity and autoantibody titers, and possibly resulting from the inability to convert FOXP3(+)CD25(-) into FOXP3(+)CD25(+) T cells. Treg frequency is highly heritable within SLE families, with specific variants of the CTLA4 and TGF genes contributing to this trait, while FOXP3 contributes to SLE through mechanisms not involving a modulation of Treg frequency. These findings establish that the genetic components in SLE pathogenesis include genes related to Treg generation or maintenance.
引用
收藏
页数:14
相关论文
共 49 条
  • [1] GOLD - Graphical Overview of Linkage Disequilibrium
    Abecasis, GR
    Cookson, WOC
    [J]. BIOINFORMATICS, 2000, 16 (02) : 182 - 183
  • [2] Multipoint quantitative-trait linkage analysis in general pedigrees
    Almasy, L
    Blangero, J
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (05) : 1198 - 1211
  • [3] Phenotype, localization, and mechanism of suppression of CD4+CD25+ human thymocytes
    Annunziato, F
    Cosmi, L
    Liotta, F
    Lazzeri, E
    Manetti, R
    Vanini, V
    Romagnani, P
    Maggi, E
    Romagnani, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) : 379 - 387
  • [4] Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus
    Barreto, M
    Santos, E
    Ferreira, R
    Fesel, C
    Fontes, MF
    Pereira, C
    Martins, B
    Andreia, R
    Viana, JF
    Crespo, F
    Vasconcelos, C
    Ferreira, C
    Vicente, AM
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2004, 12 (08) : 620 - 626
  • [5] A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes
    Bassuny, WM
    Ihara, K
    Sasaki, Y
    Kuromaru, R
    Kohno, H
    Matsuura, N
    Hara, T
    [J]. IMMUNOGENETICS, 2003, 55 (03) : 149 - 156
  • [6] Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4+25+ immunoregulatory T cells
    Bensinger, SJ
    Bandeira, A
    Jordan, MS
    Caton, AJ
    Laufer, TM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (04) : 427 - 438
  • [7] Boden Elisa, 2003, Novartis Found Symp, V252, P55
  • [8] DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS
    BOMBARDIER, C
    GLADMAN, DD
    UROWITZ, MB
    CARON, D
    CHANG, CH
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (06): : 630 - 640
  • [9] CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease
    Cao, DJ
    van Vollenhoven, R
    Klareskog, L
    Trollmo, C
    Malmström, V
    [J]. ARTHRITIS RESEARCH & THERAPY, 2004, 6 (04) : R335 - R346
  • [10] Quantification of regulatory T cells in patients with systemic lupus erythematosus
    Crispin, JC
    Martínez, A
    Alcocer-Varela, J
    [J]. JOURNAL OF AUTOIMMUNITY, 2003, 21 (03) : 273 - 276